We are live on ! Find out more
LKFT

Lakefront Biotherapeutics American Depositary Shares
LKFT

84 hedge funds and large institutions have $551M invested in Lakefront Biotherapeutics American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more funds holding

Funds holding: 82 → 84 (+2)

10% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 21

4% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 23

0.02% more ownership

Funds ownership: 19.64% → 19.66% (+0.02%)

23% less capital invested

Capital invested by funds: $720M → $551M (-$169M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

54% less call options, than puts

Call options by funds: $6.6M | Put options by funds: $14.2M

Holders
84
Holders Change
+2
Holders Change %
+2.44%
% of All Funds
1.45%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
23
Increased
24
Reduced
23
Closed
21
Calls
$6.6M
Puts
$14.2M
Net Calls
-$7.64M
Net Calls Change
-$10M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$22.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$7.73M
3
Millennium Management
Millennium Management
New York
+$6.97M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$6.62M
5
FC
Finepoint Capital
Massachusetts
+$6.16M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$16.9M
2
JP Morgan Chase
JP Morgan Chase
New York
-$15M
3
Optiver Holding
Optiver Holding
Netherlands
-$10.6M
4
DCM
Driehaus Capital Management
Illinois
-$9.33M
5
IC
Ikarian Capital
Texas
-$4.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$2.83M -$3.78M -73,810 -53%
ECM
27
Endurant Capital Management
California
$2.17M -$30.1K -588 -1%
CC
28
Carlson Capital
Texas
$1.92M +$512K +10,000 +29%
Goldman Sachs
29
Goldman Sachs
New York
$1.87M +$1.23M +23,970 +121%
DCM
30
DAFNA Capital Management
California
$1.82M – – –
AA
31
ALPS Advisors
Colorado
$1.54M -$152K -2,961 -8%
AllianceBernstein
32
AllianceBernstein
Tennessee
$1.28M -$1.73M -33,790 -53%
AA
33
AlphaCentric Advisors
Puerto Rico
$1.28M +$1.54M +30,000 New
AC
34
Apogem Capital
New York
$1.22M +$45.2K +883 +3%
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$1.16M +$1.4M +27,239 New
HS
36
HighVista Strategies
Massachusetts
$746K +$292K +5,698 +48%
Marshall Wace
37
Marshall Wace
United Kingdom
$732K +$879K +17,149 New
CCIA
38
Campbell & Co Investment Adviser
Maryland
$663K +$796K +15,541 New
PCM
39
Prelude Capital Management
New York
$625K +$615 +12 +0.1%
Point72 Asset Management
40
Point72 Asset Management
Connecticut
$597K +$717K +14,000 New
TI
41
Trexquant Investment
Connecticut
$548K +$659K +12,861 New
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
$501K -$303K -5,919 -33%
GF
43
Gabelli Funds
New York
$452K +$17.9K +350 +4%
Geode Capital Management
44
Geode Capital Management
Massachusetts
$430K – – –
MAM
45
Monaco Asset Management
Monaco
$426K +$512K +10,000 New
Wells Fargo
46
Wells Fargo
California
$391K -$17.7K -346 -4%
American Century Companies
47
American Century Companies
Missouri
$384K +$2.92K +57 +0.6%
TD Asset Management
48
TD Asset Management
Ontario, Canada
$376K +$456K +8,900 New
ACM
49
Aquatic Capital Management
Illinois
$350K +$307K +6,000 +273%
Balyasny Asset Management
50
Balyasny Asset Management
Illinois
$347K +$417K +8,147 New
1
2
3 4 5

LKFT Hedge Fund Activity: Q3 2022 in Review

84 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q3 2022, worth a combined $551M — down 23% from $720M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new LKFT positions and 21 closed out — a net gain of 2 holders — while 24 added to existing stakes and 23 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $22.1M. The largest seller was Jennison Associates, exiting entirely with an estimated $16.9M sold.

  • 84 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q3 2022, up from 82 in Q2 2022.
  • Funds reported $551M of Lakefront Biotherapeutics American Depositary Shares stock for Q3 2022, down 23% quarter-over-quarter.
  • 23 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q3 2022 and 21 closed out, a net change of +2 holders.
  • The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q3 2022 was Wellington Management Group, an estimated $22.1M added.
  • The largest Lakefront Biotherapeutics American Depositary Shares seller in Q3 2022 was Jennison Associates, an estimated $16.9M sold.

Based on aggregated 13F filings for Q3 2022.